Provision of an Exosome and Macrovesicle Quantification and Profiling System

Public Health England (PHE) requires the provision of an Exosome and Macrovesicle Quantification and Profiling System for use in its Cancer Mechanisms and Biomarkers Group laboratories. The system will be used mainly for elucidating the role of extracellular vesicles in propagating bystander effects and mediating the risk of Acute Myeloid Leukaemia (AML) development in the bone marrow. The proposed solution MUST be able to fulfil all of the following requirements: - Be able to quantify extracellular vesicles on a p...